Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating Hormone Therapy to Achieve Optimal Doses in Metastatic Prostate Cancer

NCT07751133 is registered in ClinicalTrials.gov with University College, London as lead sponsor.

NCT NCT07751133
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07751133 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating Hormone Therapy to Achieve Optimal Doses in Metastatic Prostate Cancer
Lead sponsor
University College, London
Phase
Phase 3
Overall status
Recruiting
Start date
August 28, 2026
Completion date
August 1, 2033
Enrollment
1,500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mcrpc, mhspc, prostate cancer